CINECA IRIS Institutional Research Information System

GUGLIESI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.873
EU - Europa 2.963
AS - Asia 2.809
SA - Sud America 321
AF - Africa 108
OC - Oceania 35
Totale 11.109
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.780
IT - Italia 1.149
SG - Singapore 1.035
CN - Cina 814
IE - Irlanda 261
BR - Brasile 258
SE - Svezia 248
DE - Germania 242
GB - Regno Unito 191
KR - Corea 185
AT - Austria 178
FR - Francia 139
FI - Finlandia 138
IN - India 138
JP - Giappone 109
VN - Vietnam 103
HK - Hong Kong 94
UA - Ucraina 82
SA - Arabia Saudita 74
CA - Canada 73
PL - Polonia 71
ID - Indonesia 69
SN - Senegal 49
NL - Olanda 48
BE - Belgio 47
TR - Turchia 39
ES - Italia 31
TW - Taiwan 29
AU - Australia 27
RU - Federazione Russa 24
DK - Danimarca 21
GR - Grecia 21
PK - Pakistan 21
AR - Argentina 20
IL - Israele 20
CO - Colombia 19
IR - Iran 19
MX - Messico 16
BD - Bangladesh 14
NO - Norvegia 13
CH - Svizzera 12
IQ - Iraq 12
UG - Uganda 12
ZA - Sudafrica 12
EC - Ecuador 11
MA - Marocco 8
NZ - Nuova Zelanda 8
TH - Thailandia 8
HR - Croazia 7
LT - Lituania 7
CZ - Repubblica Ceca 6
JO - Giordania 6
PH - Filippine 6
TN - Tunisia 6
AE - Emirati Arabi Uniti 5
VE - Venezuela 5
BG - Bulgaria 4
PT - Portogallo 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
EG - Egitto 3
ET - Etiopia 3
KE - Kenya 3
LU - Lussemburgo 3
RO - Romania 3
CI - Costa d'Avorio 2
HU - Ungheria 2
MY - Malesia 2
PY - Paraguay 2
RS - Serbia 2
UZ - Uzbekistan 2
ZM - Zambia 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
GH - Ghana 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MU - Mauritius 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
RW - Ruanda 1
SC - Seychelles 1
TG - Togo 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
YE - Yemen 1
Totale 11.109
Salva come PNG Salva come JPEG
Città #
Chandler 679
Singapore 610
Ashburn 376
Beijing 284
Santa Clara 280
Dublin 258
Dallas 211
Turin 194
Vienna 159
Houston 156
Fairfield 150
Torino 137
Ann Arbor 120
Sovicille 115
Los Angeles 106
Hefei 99
Seoul 99
Nyköping 95
Seattle 85
Columbus 83
Woodbridge 83
Jacksonville 82
Wilmington 75
Dearborn 70
Jakarta 68
New York 68
Munich 65
Cambridge 60
Princeton 60
Medford 58
Villeurbanne 58
Warsaw 58
Guangzhou 51
Milan 50
Pisa 50
Redwood City 45
Buffalo 44
Dong Ket 44
Rome 43
Jeddah 41
Boston 39
Bengaluru 38
Fremont 38
Boardman 37
Turku 36
Shanghai 34
Brusasco 32
Hong Kong 32
Lappeenranta 30
Frankfurt am Main 27
São Paulo 27
Tokyo 27
Washington 24
Mumbai 23
Redondo Beach 23
Brussels 22
Ho Chi Minh City 22
Pittsburgh 22
London 19
Nanjing 18
Taipei 18
Denver 17
Helsinki 17
Stockholm 17
Florence 16
San Mauro Torinese 16
Toronto 16
Chennai 15
Gongju 15
Norwalk 15
Orange 15
Phoenix 15
San Diego 15
Atlanta 14
Cardiff 14
Ta'if 14
Chicago 13
Rochester 13
Aarhus 12
Baltimore 12
Birmingham 12
Hebei 12
Istanbul 12
Kampala 12
Maddaloni 12
Montreal 12
Nuremberg 12
Bogotá 11
Lahore 11
Manchester 11
Novara 11
Philadelphia 11
Piemonte 11
San Francisco 11
Brooklyn 10
Poplar 10
Rio de Janeiro 10
Thebes 10
Hanoi 9
Hanover 9
Totale 6.557
Salva come PNG Salva come JPEG
Nome #
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 365
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease. 364
Up-regulation of the interferon-inducible IFI16 gene by oxidative stress triggers p53 transcriptional activity in endothelial cells 334
The proapoptotic activity of the Interferon-inducible gene IFI16 provides new insights into its etiopathogenetic role in autoimmunity. 270
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 267
A novel role of the interferon-inducible protein IFI16 as inducer of proinflammatory molecules in endothelial cells 232
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 230
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 217
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 212
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 208
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 201
Investigating PAD-mediated citrullination in HPV-driven head and neck squamous cell carcinoma 198
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 196
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 190
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 190
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 183
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 168
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 168
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane Binding 166
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 160
La proteina interferon-inducibile ifi16: fattore di restrizione per la replicazione degli herpesvirus umani 155
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 154
Intrinsic host restriction factors of human cytomegalovirus replication and mechanisms of viral escape 153
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 151
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 148
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 147
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 145
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 144
Where do we stand after decades of studying human cytomegalovirus? 141
Bifunctional role of interferon inducible IFI16 protein inside and outside of endothelial cells 138
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 136
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 135
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 134
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 133
Tuning the Orchestra: HCMV vs. Innate Immunity. 129
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 125
45th International Herpesvirus Workshop 117
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 116
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 111
50° Congresso Nazionale della Società Italiana di Microbiologia 110
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 109
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 105
Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. 104
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 103
The epithelial-mesenchymal transition induced by keratinocyte growth conditions is overcome by E6 and E7 from HPV16, but not HPV8 and HPV38: characterization of global transcription profiles. [*Azzimonti B, *Dell'Oste V, co-first authors] 102
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 100
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 100
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 99
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 98
Targeting PAD-mediated citrullination to treat human papillomavirus infections 97
HERPES SIMPLEX VIRUS TYPE 1 EXPLOITS LIPID METABOLISM: IMPLICATIONS FOR VIRAL INFECTIVITY AND ALZHEIMER’S DISEASE 94
Detection of IFI16 in body fluids 94
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 93
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 93
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 92
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 92
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 92
The interferon-inducible gene IFI16, a member of the HIN200 family, triggers primary endothelial cell apoptosis through caspase 2 and caspase 3 pathway 91
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 90
The interferon-inducible IFI16 gene acts as a restriction factor for human citomegalovirus replication 89
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 87
Biotechnology, Industry and Research in Piemonte from 1990 to 2003 : an update 87
The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity. 86
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 86
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 83
Tumor-derived endothelial cells evade apoptotic activity of the interferon-inducible IFI16 gene 82
Citrullination profile analysis reveals peptidylarginine deaminase 3 as an HSV-1 target to dampen the activity of candidate antiviral restriction factors 81
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 80
Role of the interferon-inducible IFI16 gene in the induction of ICAM-1 by TNF-alpha 80
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 80
Nuclear DNA sensor IFI16 as circulating protein in autoimmune diseases is a signal of damage that impairs endothelial cells through high-affinity membrane binding 77
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 77
Antiherpetic Activity of a Root Exudate from Solanum lycopersicum [*Valentina Dell'Oste, Marco Blangetti co-corresponding authors; † Greta Bajetto, Davide Arnodo co-first authors] 76
The Impact of Fatty Acid Synthase on HSV-1 Infectivity Unveils the Key Interconnection with Alzheimer’s Disease 74
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 68
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 68
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 67
Citrullination upon viral infection: a new strategy for host-targeting antivirals drugs 65
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 63
Targeting PAD-mediated citrullination to treat human papillomavirus infections 60
PAD-mediated citrullination is a novel candidate diagnostic marker and druggable target for HPV-associated cervical cancer 58
Targeting Peptidylarginine Deiminase 3 to Efficiently Suppress Herpes Simplex Virus Type 2 Infection 58
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 57
INVESTIGATING PAD-MEDIATED CITRULLINATION IN HPV-DRIVEN HEAD AND NECK SQUAMOUS CELL CARCINOMA 56
Peptidylarginine deiminase 4 (PAD4) is a key factor for SARS-CoV-2 replication and SARS-CoV-2-induced pro-inflammatory responses 55
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 48
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 44
Metabolomic and Genomic Characterization of Human Cytomegalovirus in Congenital Infection: Towards Predictive Biomarkers of Clinical Outcome 41
The impact of fatty acid synthase on HSV-1 infection dynamics [*Camilla Albano, Linda Trifirò co-first authors] 34
Interplay Between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 34
INTERPLAY BETWEEN HCMV PROTEIN pp65 AND cGAS-STING PATHWAY: MODULATING VIRAL INFECTIVITY VIA LIPID METABOLISM 28
The Impact of Fatty Acid Synthase on HSV-1 Infection Dynamics 27
ANTIHERPETIC ACTIVITY OF IMIQUIMOD-BASED RUTHENIUM METAL COMPLEXES 25
Targeting HSV-1 through FASN inhibitors: implications for Alzheimer's Disease 20
Interplay between HCMV Protein pp65 and cGAS-STING Pathway: Modulating Viral Infectivity via Lipid Metabolism 19
Totale 11.309
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.389
article - articoli 0
book - libri 0
conference - conferenze 20.622
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.011
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021558 0 0 0 0 62 57 83 52 60 88 42 114
2021/2022835 65 22 53 82 35 30 32 35 35 63 234 149
2022/20231.853 99 109 29 237 201 423 91 152 268 55 89 100
2023/20241.039 142 154 74 51 90 105 49 68 22 65 82 137
2024/20252.559 83 267 222 210 406 180 140 137 143 142 264 365
2025/20262.176 583 332 370 722 169 0 0 0 0 0 0 0
Totale 11.309